Repeated exposure rather than the total volume of transfused components may influence the incidence of allergic transfusion reactions

被引:10
作者
Kato, Hidefumi [1 ]
Nakayama, Takayuki [1 ]
Uruma, Motoaki [1 ]
Okuyama, Yoshiki [2 ]
Handa, Makoto [3 ]
Tomiyama, Yoshiaki [4 ]
Shimodaira, Shigetaka [5 ]
Takamoto, Shigeru [1 ,6 ]
机构
[1] Aichi Med Univ, Dept Transfus Med, Nagakute, Aichi 4801195, Japan
[2] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Transfus & Cell Therapy, Tokyo, Japan
[3] Keio Univ, Dept Transfus Med & Cell Therapy, Tokyo, Japan
[4] Osaka Univ Hosp, Dept Blood Transfus, Suita, Osaka, Japan
[5] Shinshu Univ Hosp, Div Transfus Med, Matsumoto, Nagano, Japan
[6] Japanese Red Cross Hokkaido Block Blood Ctr, Sapporo, Hokkaido, Japan
关键词
PLATELET; ALLOIMMUNIZATION; HAEMOVIGILANCE; RISK;
D O I
10.1111/trf.13201
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUNDThe plasma fraction of blood components has an essential role in the etiology of allergic transfusion reactions (ATRs). The difference of incidences of ATRs between fresh-frozen plasma (FFP) and platelet concentrates (PCs), in which plasma is the main component, is not clearly understood. This study compares the frequency of ATRs to FFP versus PCs on both first and subsequent (nonfirst) transfusions and considers the factors influencing the risk of ATRs. STUDY DESIGN AND METHODSFive hospitals agreed to systematically collect and share 2 years of data (January 2010 through December 2011). This was a retrospective observational analysis of data including the number of transfusion episodes and ATRs for FFP and PCs on first-transfusion patients (without transfusion history) and previously transfused patients. RESULTSThe incidence of ATRs to PCs (2.51%) was significantly higher than to FFP (1.68%) on subsequent transfusions (p<0.001). On the other hand, there were no significant differences in the incidences of ATRs to FFP (2.67%) and PCs (2.82%) on first transfusions. This discrepancy was most pronounced among males: FFP versus PCs on first transfusions, 2.02% versus 2.60% (p=0.30); and on subsequent transfusions, 1.58% versus 2.46% (p=0.0007). Among females, FFP versus PCs on first transfusions was 3.59% versus 3.13% (p=0.61) and on subsequent transfusions was 1.87% versus 2.61% (p=0.029). CONCLUSIONRepeated exposure rather than the total volume of transfused components may influence the incidence of ATRs.
引用
收藏
页码:2576 / 2581
页数:6
相关论文
共 21 条
[1]  
Ahmed S G, 2002, Niger Postgrad Med J, V9, P137
[2]   Therapies for allergic inflammation: refining strategies to induce tolerance [J].
Akdis, Cezmi A. .
NATURE MEDICINE, 2012, 18 (05) :736-749
[3]  
[Anonymous], PROP STAND DEF SURV
[4]   A PROSPECTIVE-STUDY TO IDENTIFY THE RISK-FACTORS ASSOCIATED WITH ACUTE REACTIONS TO PLATELET AND RED-CELL TRANSFUSIONS [J].
HEDDLE, NM ;
KLAMA, LN ;
GRIFFITH, L ;
ROBERTS, R ;
SHUKLA, G ;
KELTON, JG .
TRANSFUSION, 1993, 33 (10) :794-797
[5]   Annual report of research for transfusion medicine in tokyo, 2004 in japanese [J].
Imoto, S. ;
Araki, N. ;
Shimada, E. ;
Saigo, K. ;
Nishimura, K. ;
Nose, Y. ;
Bouike, Y. ;
Hashimoto, M. ;
Mito, H. ;
Okazaki, H. .
TRANSFUSION MEDICINE, 2007, 17 (06) :455-465
[6]   Incidence of Transfusion-Related Adverse Reactions per Patient Reflects the Potential Risk of Transfusion Therapy in Japan [J].
Kato, Hidefumi ;
Uruma, Motoaki ;
Okuyama, Yoshiki ;
Fujita, Hiroshi ;
Handa, Makoto ;
Tomiyama, Yoshiaki ;
Shimodaira, Shigetaka ;
Kurata, Yoshiyuki ;
Takamoto, Shigeru .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 140 (02) :219-224
[7]   Transfusion-related adverse events in the Platelet Dose study [J].
Kaufman, Richard M. ;
Assmann, Susan F. ;
Triulzi, Darrell J. ;
Strauss, Ronald G. ;
Ness, Paul ;
Granger, Suzanne ;
Slichter, Sherrill J. .
TRANSFUSION, 2015, 55 (01) :144-153
[8]   An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment [J].
Osselaer, J. C. ;
Cazenave, J. P. ;
Lambermont, M. ;
Garraud, O. ;
Hidajat, M. ;
Barbolla, L. ;
Tardivel, R. ;
Defoin, L. ;
Waller, C. ;
Mendel, I. ;
Raidot, J. P. ;
Kandel, G. ;
De Meuter, R. ;
Fabrigli, P. ;
Dehenau, D. ;
Arroyo, J. L. ;
Padron, F. ;
Gouezec, H. ;
Corral, M. ;
Jacquet, M. ;
Sundin, D. ;
Lin, L. ;
Corash, L. .
VOX SANGUINIS, 2008, 94 (04) :315-323
[9]   Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction [J].
Paglino, JC ;
Pomper, GJ ;
Fisch, GS ;
Champion, MH ;
Snyder, EL .
TRANSFUSION, 2004, 44 (01) :16-24
[10]  
Roback JD., 2008, TECHNICAL MANUAL, V16